FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for CABENUVA (cabotegravir and rilpivirine) to update its labeling for use as a complete regimen in adults with HIV-1 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

SUPPL AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)